ANDA 91341, held by Par Pharm. Travoprost.
As of Nov 16, 2026, ANDA 91341 (Travoprost), held by Par Pharm, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 19, 2011 | Original application | Tentative approval | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Travoprost0.004% ยท solution; ophthalmic | Travoprost | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters